California-based Dr. Paul Song is a highly-regarded and board-certified radiation oncologist with 20 years of experience as a clinician and translational medicine expert. He is the founder of the Calyx Peak brand SONG, a medicinal and wellness cannabis company.
Dr. Song is passionate about using empirical evidence to develop the very best medical treatments and wellness practices, and though he has years of experience treating oncology patients—most recently as an attending physician in the Radiation Oncology department at Cedars-Sinai Medical Center in Los Angeles—it wasn't until he witnessed his father's battle with cancer that he came to appreciate the medical potential of cannabis. That experience opened his eyes to this remarkable plant and to the need for deeper research into its possibilities.
[TK: what are Dr. Song's views on cannabis? His point of view, perhaps with quotes, should go here.]
[TK: how did Calyx hook up with Dr. Song?]
Dr. Song serves as the co-chair for a Campaign for a Healthy California, and in 2013 was named the very first visiting fellow on healthcare policy in the California Department of Insurance. Since 2014, Dr. Song has served as Chief Medical Officer (CMO) to the biotech company ATGen Global and its subsidiary, NKMax, overseeing and providing clinical and regulatory support into the major aspects of clinical trials and investigational applications.
He previously acted as CMO for Cynvenio Biosystems in Thousand Oaks, California from 2015 to 2017, overseeing the application of their technology into daily clinical practice as well as directing clinical trials.
In 2013, Dr. Song was the first Visiting Fellow on health policy to the California Department of Insurance. He has also held numerous roles with increasing seniority at Berg Health. He was formally Executive Chairman of the Courage Campaign, a progressive organization of 1,200,000 members. He was also a National Board of Physicians for a Health Program.
Dr. Song received his medical degree from The George Washington University School of Medicine and Health Sciences. He went on to complete his residency as well as a fellowship in Radiation Oncology at the University of Chicago Medical Center. He is a member of the American Society of Clinical Oncology and American Society for Radiation Oncology.